FDAClass IISeptember 22, 2021

Cellex qSARS-Cov-2 Antigen Rapid Test recall

Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"

Why was Cellex qSARS-Cov-2 Antigen Rapid Test recalled?

The kit does not have an emergency use authorization (EUA).

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

All lot numbers

Product
Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
Recalling firm
Cellex
Quantity
Approximately 44,821 kits
Distribution
US Nationwide distribution in the states of CA, FL, TX, and WI.
Recall date
September 22, 2021
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls